INDIA BUSINESS WORLD - 1^st April To 15^th April - 2009

STRIDES ARCOLAB GETS FDA NOD

Pharmaceutical firm Strides Arcolab has said that it has received nod from US administration for dose combination of Lamivudine and Stavudine tablets used to treat adults and children who are infected with HIV. It has received approval from the United States Food and Drug Administration for one new drug application for fixed dose combination of Lamivudine and Stavudine tablets, Strides Arcolab said in a filing to BSE. Combination of Lamivudine and Stavudine tablets in 150mg/30mg strength is used in combination with other antiretroviral drugs to treat adults and children who are infected with HIV (human immunodeficiency virus), the virus that causes AIDS.